Anika Therapeutics (ANIK) Gains from Sales and Divestitures (2018 - 2026)
Anika Therapeutics (ANIK) recorded Gains from Sales and Divestitures of $32,000 in Q2 2026, down 84.4% from $205,000 a year earlier and down 38.5% from the prior quarter.
Powered by 
Analysis
Anika Therapeutics (ANIK) Gains from Sales and Divestitures (2018 - 2026) Analysis & Trends
On a TTM basis, Anika Therapeutics' Gains from Sales and Divestitures came in at -$255,000 as of Jun 30, 2026; for FY2025, it came in at $166,000.
- Across earlier years, Gains from Sales and Divestitures came in at -$2.86 million in FY2024, -$1.92 million in FY2023 and -$993,000 in FY2021.
- Quarterly Gains from Sales and Divestitures has ranged from -$2.77 million in Q4 2024 to $451,000 in Q3 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at $52,000 (Q1 2026), -$790,000 (Q4 2025) and $451,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 242.18 Bn | 221.33 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 168.71 Bn | 139.79 Bn | 7.27 Bn |
| 3 | Danaher | 150.46 Bn | 134.27 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 138.71 Bn | 118.26 Bn | 1.96 Bn |
| 5 | Medtronic | 110.54 Bn | 76.41 Bn | 6.34 Bn |
| 6 | Stryker | 105.66 Bn | 91.78 Bn | 4.50 Bn |
| 7 | Boston Scientific | 61.74 Bn | 56.75 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 49.09 Bn | 33.21 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 48.16 Bn | 45.31 Bn | 2.32 Bn |
| 10 | Anika Therapeutics | 255.62 Mn | -10.93 Mn | 21.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32,000.00 |
| Mar 31, 2026 | 52,000.00 |
| Dec 31, 2025 | -790,000.00 |
| Sep 30, 2025 | 451,000.00 |
| Jun 30, 2025 | 205,000.00 |
| Mar 31, 2025 | 300,000.00 |
| Dec 31, 2024 | -2.77 Mn |
| Sep 30, 2024 | -97,000.00 |
| Dec 31, 2023 | -65,000.00 |
| Dec 31, 2021 | -162,000.00 |
| Mar 31, 2021 | -831,000.00 |
| Dec 31, 2020 | 22,000.00 |
| Sep 30, 2020 | -22,000.00 |
| Jun 30, 2020 | -265,000.00 |
| Sep 30, 2019 | -206,000.00 |
| Mar 31, 2019 | -721,000.00 |
| Dec 31, 2018 | 20,000.00 |
| Jun 30, 2018 | -30,000.00 |
| Mar 31, 2018 | -142,000.00 |
API Access
Anika Therapeutics Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ANIK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "ANIK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=ANIK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();